EUVIMEDEUVIMED entdecken
Open Access

Impeding Nucleotide‐Binding Oligomerization Domain‐Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity‐Associated Cardiomyopathy

Shi-Qiang Liu iD, Sai-Yang Xie iD, Tong Zhang, Heng Zhang iD, Meng-Ya Chen, Yun Xing, Nan Zhao iD, Lanlan Li, Si Chen, Sha-Sha Wang, Xiao-Feng Zeng, Wei Deng und 1 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Shi-Qiang Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Renmin Hospital of Wuhan University Wuhan PR China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Obesity, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation and metabolic disturbances are key culprits in the pathogenesis of obesity‐associated cardiomyopathy. The NLRP3 (nucleotide‐binding oligomerization domain‐like receptor 3) inflammasome mediates the release of the proinflammatory cytokines IL‐1β (interleukin‐1β) and IL‐18 by activating caspase‐1, which is strongly implicated in metabolic disturbances. We here sought to determine whether NLRP3 inflammasome inhibition could ameliorate obesity cardiomyopathy and if so, to further explore its underlying mechanisms. Methods and Results Male mice were fed a high‐fat diet for 24 weeks to induce obesity cardiomyopathy. MCC950 was used to inhibit NLRP3 inflammasome activation. Recombinant adeno‐associated virus serotype 9 encoding TXNIP (thioredoxin‐interacting protein) under cTnT (cardiac troponin T) promoter and the mitochondrial‐targeted antioxidant MitoTEMPO were injected into obese mice to investigate the specific mechanism. To mimic obesity cardiomyopathy in vitro, neonatal rat ventricular myocytes transfected with the small interfering RNA against TXNIP were incubated with 400 μmol palmitic acid for 24 hours. NLRP3 inflammasome was significantly increased in obese hearts. NLRP3 inflammasome inhibition by NLRP3 deletion or MCC950 prevented obesity‐induced cardiac systolic and diastolic dysfunction, myocardial hypertrophy and fibrosis, and excessive lipid accumulation in male mice. Conversely, TXNIP overexpression worsened obesity‐associated cardiomyopathy. Similarly, MCC950 treatment or TXNIP knockdown reduced palmitic acid‐induced NLRP3 inflammasome activation and lipid storage. Mechanistically, abnormal NF‐κB (nuclear factor kappa B) pathway activation, increased mitochondrial reactive oxygen species, and elevated TXNIP levels led to excessive NLRP3 inflammasome activation.

Conclusions

Our study confirms that aberrant NLRP3 inflammasome activation in cardiomyocytes worsens obesity‐associated cardiomyopathy and implicates inhibition of NLRP3 inflammasome as a potent therapeutic approach for obesity cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesObesityCardiomyopathiesVentricular RemodelingMice, Inbred C57BLAnimalsMaleMiceDisease Models, AnimalCarrier ProteinsMyocytes, CardiacFuransDiet, High-FatIndenesHeterocyclic Compounds, 4 or More RingsSignal TransductionReactive Oxygen SpeciesRatsCells, CulturedMice, KnockoutThioredoxinsNF-kappa BVentricular Function, LeftOrganophosphorus CompoundsPiperidines

Stichwörter der Autor:innen

MCC950MitoTEMPOTXNIPheart failuremitochondrial reactive oxygen speciesnuclear factor kappa B

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, mouseCarrier ProteinsN-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamideFuransIndenesTxnip protein, mouseHeterocyclic Compounds, 4 or More RingsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiology Renmin Hospital of Wuhan University Wuhan PR China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases Wuhan PR China.
  • Cardiovascular Research Institute of Wuhan University Wuhan PR China.

ORCID-Profile: Shi-Qiang Liu, Sai-Yang Xie, Heng Zhang, Nan Zhao, Qi-Zhu Tang

Zitieren

APA

Liu, S. Q., Xie, S. Y., Zhang, T., Zhang, H., Chen, M. Y., Xing, Y., Zhao, N., Li, L., Chen, S., Wang, S. S., Zeng, X. F., Deng, W., & Tang, Q. Z. (2024). Impeding Nucleotide‐Binding Oligomerization Domain‐Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity‐Associated Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035234

Vancouver

Liu SQ, Xie SY, Zhang T, Zhang H, Chen MY, Xing Y, et al. Impeding Nucleotide‐Binding Oligomerization Domain‐Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity‐Associated Cardiomyopathy. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035234

BibTeX
@article{Liu2024,
  author = {Liu, Shi-Qiang and Xie, Sai-Yang and Zhang, Tong and Zhang, Heng and Chen, Meng-Ya and Xing, Yun and Zhao, Nan and Li, Lanlan and Chen, Si and Wang, Sha-Sha and Zeng, Xiao-Feng and Deng, Wei and Tang, Qi-Zhu},
  title = {Impeding Nucleotide‐Binding Oligomerization Domain‐Like Receptor 3 Inflammasome Ameliorates Cardiac Remodeling and Dysfunction in Obesity‐Associated Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035234}
}
Kostenlos starten →